Skip to main content

and
  1. Article

    Open Access

    Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

    Current approaches for treating metastatic malignant melanoma (MM) are not effective enough and are associated with serious adverse events. Due to its immunogenicity, melanoma is an attractive target for immun...

    Angelica Loskog, Aglaia Maleka, Sara Mangsbo, Emma Svensson in British Journal of Cancer (2016)